Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 22681 - 22700 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FF02) pembrolizumab | Keytruda 100 mg/4 mL injection, 4 mL vial | Solution concentrate for I.V. infusion 100 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&Dohme(Australia)PtyLtd |
| Australia | (L01FF02) pembrolizumab | Keytruda 100 mg/4 mL injection, 4 mL vial | Solution concentrate for I.V. infusion 100 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&Dohme(Australia)PtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Solution concentrate for I.V. infusion 120 mg in 2.4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF03) durvalumab | Imfinzi 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaPtyLtd |
| Australia | (L01FF04) avelumab | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
| Australia | (L01FF04) avelumab | Bavencio 200 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 200 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckHealthcarePtyLtd |
Pages
